Antiviral agents.

Slides:



Advertisements
Similar presentations
Antiviral Agents Kishore Wary
Advertisements

Antiviral agents Pawitra Pulbutr M.Sc. In Pharm (Pharmacology)
ANTI VIRAL Agents Kaukab Azim, MBBS, PhD Modified by: iSRAA.
Antivirals Slackers Facts by Mike Ori. Disclaimer The information represents my understanding only so errors and omissions are probably rampant. It has.
Copyright © 2014 by Mosby, an imprint of Elsevier Inc.
Vaccines and Antivirals. Clinical Use of Interferon Therefore they have been used in the treatment of cancers of various types. Therefore they have been.
1 Inhibitors of Other Viruses A. RIBAVIRIN Ribavirin (Virazole) is a nucleoside analogue in which a triazolecarboxamide moiety is substituted on place.
ANTIVIRAL AND ANTIRETROVIRAL DRUGS 1 University Of Nairobi Department Of Public Health, Pharmacology & Toxicology JPT 341 Pharmacology &Toxicology BVM.
Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 40 Antiviral Drugs.
Antiviral Drugs.
Antiviral Agents Scott M. Hammer, M.D.. Challenges to the Development of Effective Antiviral Agents Myriad number of agents Need knowledge of replication.
D7 - Antivirals Differences between bacteria and viruses How does antiviral drugs work? The AIDS problem.
Antiviral Agents.
Antiviral Agents Viruses - The target of antiviral drugs.
Anti-viral drugs Viruses have no cell wall and made up of nucleic acid components Viruses containing envelope – antigenic in nature Viruses are obligate.
ANTIVIRALS, INTERFERON AND VACCINES
Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc. Chapter 92 Antiviral Agents I: Drugs for Non- HIV Viral Infections.
Hepatitis LINK Viral Hepatitis is a group of disease that infect the liver. Three viruses - Hepatitis A, Hepatitis B and Hepatitis C are the most frequent.
September 15, 1997Copyright Robert Rapp, University of Kentucky College of Pharmacy Viral Infections Part 1 and 2 Robert P. Rapp, Pharm. D. Professor College.
Agents in the therapy of DNA and RNA Viruses
Antiviral Chemotherapy Discovery of antiviral drugs Targets of antiviral drugs.
Antiviral Agents Upton D. Allen. Outline of Presentation Herpes group agents Anti-influenza agents Anti-hepatitis agents Anti-RSV Immune response modifiers.
Antiviral Agents Restricted spectrum
Antiviral drugs By S.Bohlooli, PhD
Virology – Antivirals 1 JU- 2 nd Year Medical Students By Dr Hamed AlZoubi – Microbiology and Immunology Department – Mutah University. MBBS (J.U.S.T)
Antiviral Drugs Prof. Alhaider, 1431 H Definition: Viral infections depend on the host cells. Therefore, antiviral drugs must block viral entry or exit.
The head of a pin can hold five hundred million rhinoviruses (cause of the common cold). One sneeze can generate an aerosol of enough cold viruses to.
The head of a pin can hold five hundred million rhinoviruses (cause of the common cold). One sneeze can generate an aerosol of enough cold viruses to infect.
Anti-viral Drugs.. Introduction The viral agents kill viruses by inhibiting their ability to replicate, but there are currently only about a dozen such.
Antiviral Drugs. Mechanism of Action Picornaviruses eg, polioviruses, cold viruses Block attachment molecule on host cell or pathogen Attachment antagonists.
Antiviral Agents Scott M. Hammer, M.D.. Challenges to the Development of Effective Antiviral Agents Myriad number of agents Need knowledge of replication.
Antiviral Agents.
The head of a pin can hold five hundred million rhinoviruses (cause of the common cold). One sneeze can generate an aerosol of enough cold viruses to infect.
Antiviral Agents, chapter 39 Different living organisms.
Antifungal Drugs Inhibition of ergosterol synthesis Polyenes
Anti-viral drugs By Dr.Mohamed Abd ALMoneim Attia.
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 39 Antiviral Drugs.
Antiviral therapy E.McNamara. Challenges Virus parasitize host cells Target the virus specifically Latency, quiescent phase Is treatment necessary? Efficacy.
Antimicrobial drugs. Antimicrobial drugs are effective in the treatment of infections because of their selective toxicity (that is, they have the ability.
 Recognition  Attachment  Penetration  Uncoating  Early protein synthesis  Nucleic acid synthesis  Late protein synthesis  Assembly  Release.
Antivirals Lect 7,8 Sadia Anjum. Targets for Anti-viral therapy 1. viral attachment to cell and fusion (fusion inhibitors) 2. protein translation in infected.
The head of a pin can hold five hundred million rhinoviruses (cause of the common cold). One sneeze can generate an aerosol of enough cold viruses to infect.
ANTIVIRAL AGENTS.
ANTIVIRAL THERAPY DR FATAI OLUYADI USMLEINCLINED.COM 1.
Antiviral Therapy. Table for antiviral Drug:Viruses: Chemical Type: Target: Acyclovir, VidarabineHerpesviruses (HSV) Nucleoside analogues Virus polymerase.
ANTIVIRAL DRUGS DR. SOE AUNG MYINT Monday.
Antiviral Agents Dr. Yunita Sari Pane, MS 06 August DEPARTEMEN FARMAKOLOGI & TERAPEUTIK FK USU.
Viro100: Virology 3 Credit hours NUST Centre of Virology & Immunology
Virology – Antivirals 2 JU- 2 nd Year Medical Students By Dr Hamed AlZoubi – Microbiology and Immunology Department – Mutah University. MBBS (J.U.S.T)
Prevention & Treatment of Viral Diseases Abira Khan.
Antiviral agents Hamzeh Elayan
Pharmacology of Antiviral Agents
Antiviral Drugs Viruses are obligate intracellular parasites.
Antiviral Drugs.
Antiviral drugs.
ANTIVIRAL AGENTS.
By Dr.Mohamed Abd ALMoneim Attia
Copyright © 2017, Elsevier Inc. All rights reserved.
Antiviral chemotherapy
Antiviral Drugs.
Antiviral drugs Mr. OLORO JOSEPH..
Principles of Pharmacology The Pathophysiologic Basis of Drug Therapy
Assist . Prof . Karima F. Ali Al-Mustansiriyah university
Antiviral Drugs Viruses are obligate intracellular parasites.
Antiviral Review 22 November :45 PM.
Antiviral Drugs Chapter 45.
Antiherpes Drugs 30 November :40 PM.
Antiviral Agents.
Antiviral Agents Mr. Sachin Shinde S. M. Joshi College Hadapsar, Pune
Antiviral chemotherapy
Presentation transcript:

Antiviral agents

Viruses treatable with antiviral drugs HSV VZV CMV HIV Influenza A and B Respiratory syncytial virus (RSV) Hepatitis A, B, and C viruses (HAV;HBV;HCV) Papilloma Picornavirus

Agents active against Herpesviruses-I Acyclovir Cidofovir Famciclovir and penciclovir Foscarnet Fomivirsen

Agents active against Herpesviruses-II Ganciclovir Valacyclovir Valganciclovir Vidarabine Topical agents: -Trifluridine -Vidarabine

Revolution in the field of Infectious diseases: The availability of Increasing number of antiviral agents Against a broadening spectrum of viral pathogens

Mechanism of action of antiviral agents is essential , for appropriate clinical use and for understanding and managing antiviral resistance !

Acyclovir HSV encephalitis Neonatal HSV infection Primer genital HSV Mucosal and cutaneous HSV-1 and HSV-2 infections in immunocompromised patients VZV infection Recurrent genital herpes

Acyclovir resistance Mutation either in viral TK or DNA polymerase genes.

Cidofovir Broad activity: -adenoviruses -herpesviruses -papovaviruses -poxviruses

Cidofovir Prophylaxis and treatment of CMV retinitis in patients with AIDS Acyclovir and foscarnet resistent HSV infections

Famciclovir and Penciclovir DNA polimerase inhibitor Nucleoside analogue Famciclovir: synthetic Active metobolite: penciclovir 1% topical penciclovir

Famciclovir Singles (acute zoster) Genital HSV Mucocutaneous HSV in HIV infected patients

Foscarnet Pyrophosphate analogue DNA polymerase inhibitor RT inhibitor Active agains all herpesviruses, HIV, HBV

Foscarnet CMV retinitis in AIDS patients Acyclovir resistant mucuccutaneous HSV infections in AIDS patients Gancyclovir resistant CMV pulmoner infections in AIDS patients Acyclovir resistant VZV infections in AIDS patients

Fomivirsen Inhibits viral replication by antisense mechanism: its a nucleotide sequence which is complementary to a sequence in mRNA transkript and translation is inhibited. Intravitreal injection for CMV retinitis

Ganciclovir Guanoside analogue DNA polimerase inhibitor Similar to acyclovir i.v, oral and intraocular application

Ganciclovir Prevention and treatment of CMV retinitis in AIDS patients CMV disease in transplant patients

Valacyclovir Active metobolite= acyclovir

Vidarabine Nucleosid analogue First licensed systemic antiviral agent Acyclovir has supplanted vidarabine

Topical agents for HSV keratitis Trifluridine Vidarabine

Interferons Low molecular weight proteins With complex antiviral, immunomodulating, antiproliferative activities. Produced by eucaryotic cells in response to various inducers: viruses 3 types: IFN-a, IFN-β , INF- δ IFN-a2b: widest application Pegilated- IFN-a: + polyethylene glycol to the interferon, through a process known as pegylation, enhances the half-life of the interferon when compared to its native form.

HIV(Human immunodeficeincy virus) Nucleoside analogue reverse transcriptase inhibitors:Zidovudine (azidothymidine) Non- Nucleoside analogue reverse transcriptase inhibitors Protease inhibitors Fusion inhibitors Integrase inhibitors

Hepatitis C: Interferon-a, ribavirin Hepatitis B: INF-a, lamivudine (reverse transcriptase inhibitor), adefovir, … Papillomavirus: Interferon-a RSV: Ribavirin CMV:ganciclovir, foscarnet VZV: valacyclovir, famciclovir Picornavirus: pleconaril

Anti-influenza drugs Influenza A: Amantadine Rimantadine 2. Influenza A and B Zanamivir: enzyme inhibitors of neurominidase, virus release is inhibited. Oseltamavir: the same The length of disease is reduced if taken within the first 48hours